Evidence map›Paper›PMID 28323545›Full record

ArticleTissue engineering. Part A2017

Creation of a Bioengineered Skin Flap Scaffold with a Perfusable Vascular Pedicle.

Bernhard J Jank, Jeremy Goverman, Jacques P Guyette, Jon M Charest, Mark Randolph, Glenn R Gaudette, Joshua R Gershlak, Martin Purschke, Emilia Javorsky, Rosalynn M Nazarian and 4 more

Abstract read
In one paragraph

Article in Tissue engineering. Part A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Optimized Decellularization of a Porcine Fasciocutaneaous Flap.Bioengineering (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Techniques and Innovations in Flap Engineering: A Review.Plastic and reconstructive surgery. Global open · 2022
    Article
  12. Article
  13. Decellularized vascularized bone grafts: A preliminaryFrontiers in bioengineering and biotechnology · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Bernhard J Jank1 Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
Jeremy Goverman2 Divison of Burns, Department of Surgery, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
Jacques P Guyette1 Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
Jon M Charest1 Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
Mark Randolph3 Divison of Plastic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
Glenn R Gaudette5 Worcester Polytechnic Institute , Worcester, Massachusetts.
Joshua R Gershlak5 Worcester Polytechnic Institute , Worcester, Massachusetts.
Martin Purschke6 Wellman Center for Photomedicine , Boston, Massachusetts.
Emilia Javorsky6 Wellman Center for Photomedicine , Boston, Massachusetts.
Rosalynn M Nazarian7 Department of Pathology, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
David A Leonard4 Center for Transplantation Sciences at Massachusetts General Hospital , Boston, Massachusetts.
Curtis L Cetrulo3 Divison of Plastic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
William G Austen2 Divison of Burns, Department of Surgery, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
Harald C Ott1 Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts.
Massachusetts General Hospital · USHarvard University · USWorcester Polytechnic Institute · US

Funding

Organ engineering based on perfusion decellularized matrixDP2OD008749 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI OTT, HARALD C · 2011 to 2011
$2.6M
NIH HHS DP2 OD008749
6 · The paper itself

Abstract

Full-thickness skin loss is a challenging problem due to limited reconstructive options, demanding 75 million surgical procedures annually in the United States. Autologous skin grafting is the gold standard treatment, but results in donor-site morbidity and poor aesthetics. Numerous skin substitutes are available on the market to date, however, none truly functions as full-thickness skin due to lack of a vascular network. The creation of an autologous full-thickness skin analogue with a vascular pedicle would result in a paradigm shift in the management of wounds and in reconstruction of full-thickness skin defects. To create a clinically relevant foundation, we generated an acellular skin flap scaffold (SFS) with a perfusable vascular pedicle of clinically relevant size by perfusion decellularization of porcine fasciocutaneous flaps. We then analyzed the yielded SFS for mechanical properties, biocompatibility, and regenerative potential in vitro and in vivo. Furthermore, we assessed the immunological response using an in vivo model. Finally, we recellularized the vascular compartment of an SFS and reconnected it to a recipient's blood supply to test for perfusability. Perfusion decellularization removed all cellular components with preservation of native extracellular matrix composition and architecture. Biaxial testing revealed preserved mechanical properties. Immunologic response and biocompatibility assessed via implantation and compared with native xenogenic skin and commercially available dermal substitutes revealed rapid neovascularization and complete tissue integration. Composition of infiltrating immune cells showed no evidence of allorejection and resembled the inflammatory phase of wound healing. Implantation into full-thickness skin defects demonstrated good tissue integration and skin regeneration without cicatrization. We have developed a protocol for the generation of an SFS of clinically relevant size, containing a vascular pedicle, which can be utilized for perfusion decellularization and, ultimately, anastomosis to the recipient vascular system after precellularization. The observed favorable immunological response and good tissue integration indicate the substantial regenerative potential of this platform.

Indexed as

Materials TestingSkinSurgical FlapsAnimalsRatsRats, Sprague-DawleySwineSwine, MiniatureTissue Scaffoldsacellular matricesdecellularizeddermal matrixskin scaffold

Identifiers

PMID28323545
PMCPMC5549829
OpenAlexW2600449750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.